Portfolio of Biotech Stocks: Second Portfolio
Here is a sample of 9 biotech stocks from the universe of biotechnology companies.
| 9 Biotech Stocks: Second Portfolio | ||
|---|---|---|
Name & Return | Symbol | |
| Alkermes | ALKS | |
| Ionis Pharmaceuticals | IONS | |
| Madrigal Pharmaceuticals | MDCL | |
| Neurocrine Biosciences | NBIX | |
| Regenxbio | RGNX | |
| Sarepta Therapeutics | SRPT | |
| Vanda Pharmaceuticals | VNDA | |
| Viking Therapuetics | VKTX | |
| Vir Biotechnology | VIR | |
| Display Price Chart for each stock. | ||
| Display Dividend Chart for each stock. | ||
Portfolio Values
To inspect the performance of the Biotech Stocks: Second Portfolio portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.The 8 stocks included in the portfolio computations are: ALKS, IONS, MDCL, NBIX, RGNX, SRPT, VNDA and VKTX. The current value of the portfolio assumes that $1,250.00 was invested in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. VIR was excluded from the portfolio computations because of insufficient price data.The current value of the $10,000 investment is $16,958. The percent return is 69.58%. The annualized return is 11.14%.
Related Portfolios
Portfolio of Biotech Stock: First Portfolio